Literature DB >> 22246570

Downregulation of ferroportin 1 expression in hFOB1.19 osteoblasts by hepcidin.

Youjia Xu1, Wei Zhang, Peng Zhang, Li Xiao, Aidong Wang, Pierre Sirois, Kai Li.   

Abstract

The present study was designed to address the relationship between iron homeostasis and bone metabolism. Cultured hFOB 1.19 osteoblasts were incubated with selected concentrations of hepcidin (50, 100, and 200 nmol/L) for 20 h, harvested for extraction of total RNA and proteins, and the expression of ferroportin 1 was analyzed by RT-PCR and western blotting. The results showed the presence of ferroportin 1 expression in cultured hFOB 1.19 cells. Furthermore, the ferroportin 1 had a similar expression pattern in hFOB cells as in hepatocytes and enterocytes and was downregulated by hepcidin. Our data indicate that osteoblasts are target cells for hepcidin, suggest that hepcidin may have many more targets than previously recognized, and support the role of hepcidin in the development of osteoporosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22246570     DOI: 10.1007/s10753-011-9411-8

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  11 in total

Review 1.  Mechanisms of iron accumulation in hereditary hemochromatosis.

Authors:  Robert E Fleming; William S Sly
Journal:  Annu Rev Physiol       Date:  2002       Impact factor: 19.318

2.  The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis.

Authors:  Adriana Donovan; Christine A Lima; Jack L Pinkus; Geraldine S Pinkus; Leonard I Zon; Sylvie Robine; Nancy C Andrews
Journal:  Cell Metab       Date:  2005-03       Impact factor: 27.287

Review 3.  Infection and anemia.

Authors:  Hau C Kwaan
Journal:  Infect Disord Drug Targets       Date:  2011-02

Review 4.  Hepcidin and its role in regulating systemic iron metabolism.

Authors:  Tomas Ganz
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2006

5.  Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation.

Authors:  Andrea U Steinbicker; Chetana Sachidanandan; Ashley J Vonner; Rushdia Z Yusuf; Donna Y Deng; Carol S Lai; Kristen M Rauwerdink; Julia C Winn; Borja Saez; Colleen M Cook; Brian A Szekely; Cindy N Roy; Jasbir S Seehra; Gregory D Cuny; David T Scadden; Randall T Peterson; Kenneth D Bloch; Paul B Yu
Journal:  Blood       Date:  2011-03-10       Impact factor: 22.113

6.  The hepcidin circuits act: balancing iron and inflammation.

Authors:  Bryan D Maliken; James E Nelson; Kris V Kowdley
Journal:  Hepatology       Date:  2011-05       Impact factor: 17.425

7.  Excess iron inhibits osteoblast metabolism.

Authors:  Kanako Yamasaki; Hiromi Hagiwara
Journal:  Toxicol Lett       Date:  2009-09-06       Impact factor: 4.372

Review 8.  Role of iron in osteoporosis.

Authors:  Eugene D Weinberg
Journal:  Pediatr Endocrinol Rev       Date:  2008-10

9.  The "lively" cytokines network in beta-Thalassemia Major-related osteoporosis.

Authors:  Nunziata Morabito; Giuseppina T Russo; Agostino Gaudio; Antonino Lasco; Antonio Catalano; Elisa Morini; Fabio Franchina; Domenica Maisano; Mariangela La Rosa; Maria Plota; Adolfa Crifò; Anna Meo; Nicola Frisina
Journal:  Bone       Date:  2007-03-01       Impact factor: 4.398

10.  The iron regulatory hormone hepcidin reduces ferroportin 1 content and iron release in H9C2 cardiomyocytes.

Authors:  Xiao Hu Ge; Qin Wang; Zhong Ming Qian; Li Zhu; Fang Du; Wing Ho Yung; Lei Yang; Ya Ke
Journal:  J Nutr Biochem       Date:  2008-11-22       Impact factor: 6.048

View more
  4 in total

1.  Reducing iron accumulation: A potential approach for the prevention and treatment of postmenopausal osteoporosis.

Authors:  Bin Chen; Guang-Fei Li; Ying Shen; X I Huang; You-Jia Xu
Journal:  Exp Ther Med       Date:  2015-05-08       Impact factor: 2.447

Review 2.  Iron homeostasis in osteoporosis and its clinical implications.

Authors:  G F Li; Y Z Pan; P Sirois; K Li; Y J Xu
Journal:  Osteoporos Int       Date:  2012-04-14       Impact factor: 4.507

3.  Effects of mouse hepcidin 1 treatment on osteoclast differentiation and intracellular iron concentration.

Authors:  Guo-yang Zhao; Dong-hua Di; Bo Wang; Xi Huang; You-jia Xu
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

4.  Iron regulates the expression of ferroportin 1 in the cultured hFOB 1.19 osteoblast cell line.

Authors:  Guo-Yang Zhao; Dong-Hua DI; Bo Wang; Peng Zhang; You-Jia Xu
Journal:  Exp Ther Med       Date:  2014-07-03       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.